Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, pharmacokinetics, and antiviral activity of ABI-4334 in adults with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ABI-4334 (ABI-4334)

Snippet

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED